The aim of this phase II trial was to assess the efficacy and tolerability of docetaxel/vinorelbine as second-line therapy. Thirty-two patients with a performance status (PS) of
Download full-text PDF
Source
http://dx.doi.org/10.3816/clc.2002.n.024 DOI Listing Publication Analysis
Top Keywords
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!